No items found.
Please help support Ninja Nerd to continue creating free medical videos. All donations we receive are put directly into content creation so we are able to continue providing these videos for free. Thanks!
We strongly recommend signing up through this page using our default payment processor Stripe, But if you have any issues, please send an email to the address below and we can set you up through PayPal.
Send us your details and we will get back to you with details.
Ninja Nerds!
In this lecture Professor Zach Murphy will be presenting on Antiarrhythmic Drugs. We begin this lecture by reviewing Cardiac Physiology which will be essential in order to understand how these antiarrhythmics work. We will then go through the 5 types of Antiarrhythmic Drugs which include: Sodium Channel Blockers (Type I AAD), Beta Blockers (Type II AAD), Potassium Channel Blockers (Type III AAD), Calcium Channel Blockers (Type IV AAD), Adenosine + Digoxin (Type V AAD). After discussing these classes of drugs mechanism of action and indications, we will then transition into each of these types of drugs adverse reactions. We conclude this lecture by going over practice problems for Antiarrhythmic Drugs that we will be reviewing with you. We hope you enjoy this lecture!
Table of Contents:
0:00 Lab
0:07 Antiarrhythmic Drugs (AAD) Introduction
1:35 Cardiac Physiology
49:37 Beta Blockers (Type II AAD)
57:05 Calcium Channel Blockers (Type IV AAD)
1:01:03 Adenosine + Digoxin (Type V AAD)
1:14:06 Sodium Channel Blockers (Type I AAD)
1:31:54 Potassium Channel Blockers (Type III AAD)
1:42:33 Indications for Antiarrhythmic Drugs
2:02:04 Adverse Drug Reactions: Beta Blockers (Type II AAD)
2:07:42 Adverse Drug Reactions: Calcium Channel Blockers (Type II AAD)
2:09:42 Adverse Drug Reactions: Adenosine (Type V AAD)
2:12:47 Adverse Drug Reactions: Digoxin (Type V AAD)
2:20:10 Adverse Drug Reactions: Sodium Channel Blockers (Type I AAD)
2:27:26 Adverse Drug Reactions: Potassium Channel Blockers (Type III AAD)
2:33:36 Antiarrhythmic Drugs Practice Problems
2:40:25 Comment, Like, SUBSCRIBE!
